OOIR: Observatory of International Research

Papers

(The median citation count of International Journal of Tuberculosis and Lung Disease is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
The impact of COVID-19 on TB: a review of the data	149
Post-tuberculosis lung health: perspectives from the First International Symposium	94
Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19	69
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease	59
The Global Asthma Report 2022	43
COVID-19 and tuberculosis—threats and opportunities	39
Impact of COVID-19 on TB diagnosis in Northeastern Brazil	39
New diseases and old threats: lessons from tuberculosis for the COVID-19 response	38
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria	33
Impact of COVID-19 on tuberculosis control in China	32
Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China	30
Mask wearing to complement social distancing and save lives during COVID-19	29
Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review	28
Tobacco control in China and the road to Healthy China 2030	27
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB	26
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda	24
Tuberculosis contact investigation and short-course preventive therapy among young children in Africa	24
The COVID-19 and TB syndemic: the way forward	24
Post-tuberculosis sequelae: the need to look beyond treatment outcome	24
Severe COVID-19 cases with a history of active or latent tuberculosis	23
Clinical standards for the diagnosis, treatment and prevention of TB infection	23
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis	22
A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic	21
Adapting TB services during the COVID-19 pandemic in Mumbai, India	20
Clinical standards for the dosing and management of TB drugs	20

Thrombotic events and COVID-19 vaccines	19
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?	19
The burden and determinants of post-TB lung disease	19
Post-TB health and wellbeing	19
Diagnosing pulmonary aspergillosis is much easier than it used to be: a new diagnostic landscape	19
The need for pulmonary rehabilitation following tuberculosis treatment	19
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function	19
Asbestos-related diseases	18
How TB and COVID-19 compare: an opportunity to integrate both control programmes	18
Impact of COVID-19 on tuberculosis services in India	18
Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid	18
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities	18
Impact of the global COVID-19 outbreak on the management of other communicable diseases	18
Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic	17
Resource reprioritisation amid competing health risks for TB and COVID-19	17
Critical changes to services for TB patients during the COVID-19 pandemic	17
TB and COVID-19 co-infection: rationale and aims of a global study	17
Comparative analysis of Truenat™ MTB Plus and Xpert^® Ultra in diagnosing tuberculous meningitis	16
Computer-aided detection for tuberculosis and silicosis in chest radiographs of gold miners of South Africa	16
Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis	15
Automated chest radiography and mass systematic screening for tuberculosis	15
Mortality due to TB-COVID-19 coinfection in India	15
Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms	15
Evaluation of recorded video-observed therapy for anti-tuberculosis treatment	15
Person-centred care in TB	15
WHO drug-resistant TB guidelines 2022: what is new?	14
Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?	14
Bedaquiline for multidrug-resistant TB in paediatric patients	13
TB and the COVID-19 pandemic: brothers in arms against lung health	13
Management of rifampicin‐resistant TB: programme indicators and care cascade analysis in South Africa	13
How to demystify COVID-19 and reduce social stigma	13
Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis	13
Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine	13
National population-based tuberculosis prevalence survey in Ghana, 2013	13
Availability of diagnostic services and essential medicines for non‐communicable respiratory diseases in African countries	13
TB multimorbidity: a global health challenge demanding urgent attention	13
Tuberculosis from transmission in clinics in high HIV settings may be far higher than contact data suggest	13
Let us not forget the mask in our attempts to stall the spread of COVID-19	12
Determining the value of TB active case-finding: current evidence and methodological considerations	12
Chronic obstructive pulmonary disease in sub-Saharan Africa	12
Patient-cost survey for tuberculosis in the context of patient-pathway modelling	12
A randomised controlled trial to evaluate a medication monitoring system for TB treatment	11
Real-world implementation of video-observed therapy in an urban TB program in the United States	11
First molecular-based anti-TB drug resistance survey in Eritrea	11
Tackling the threat of COVID-19 in Africa: an urgent need for practical planning	11
Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey	11
Bedaquiline and delamanid result in low rates of unfavourable outcomes among TB patients in Eswatini	11
Monocyte-to-lymphocyte ratio as a predictor of TB among people living with HIV	11
Number needed to screen for TB in clinical, structural or occupational risk groups	10
Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil	10

Breastfeeding in women living with tuberculosis	10
Sustaining essential healthcare in Africa during the COVID-19 pandemic	10
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts	10
New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India	10
The impact of COVID-19 on the diagnosis of TB in Taiwan	10
Risk factors for chronic pulmonary aspergillosis in post-TB patients	10
Evidence for pulmonary rehabilitation in chronic respiratory diseases in sub-Saharan Africa: a systematic review	10
Cost of tuberculosis treatment in low- and middle-income countries: systematic review and meta-regression	10
The impact of PM2.5 on lung function in adults with asthma	10
Predictive models for COVID-19-related deaths and infections	9
Determinants of lung health across the life course in sub-Saharan Africa	9
Serology-positive but minimally symptomatic COVID-19 may still cause lung injury and lung function impairment	9
How to manage children if a second wave of COVID-19 occurs	9
A comparison of digital chest radiography and Xpert^® MTB/RIF in active case finding for tuberculosis	9
Geographic distribution, socio-economic disparity and policy determinants of smoke-free policy adoption in Indonesia	9
Latent tuberculosis infection and the EndTB Strategy: ethical tensions and imperatives	9
Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis	9
Spatial variability in the risk of death from COVID-19 in Italy	9
First-line tuberculosis treatment with double-dose rifampicin is well tolerated	9
Cost of TB services in healthcare facilities in Kenya (No 3)	8
Linezolid use for drug-resistant tuberculosis in Georgia: a retrospective cohort study	8
The largest prison outbreak of TB in Western Europe investigated using whole-genome sequencing	8
Preparing national tuberculosis control programmes for COVID-19	8
COPD exacerbation rates are higher in non-smoker patients in India	8
Monitoring the COVID-19 pandemic in sub-Saharan Africa: focusing on health facility admissions and deaths	8
Impact of COVID-19 on patients with asthma	8
Modelling the potential impact of adherence technologies on tuberculosis in India	8
Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis	8
Detection of Mycobacterium tuberculosis cell-free DNA to diagnose TB in pediatric and adult patients	8
The war in Ukraine and potential consequences for the TB epidemic in Europe	8
Priorities among HIV-positive individuals for tuberculosis preventive therapies	8
UNITE4TB: a new consortium for clinical drug and regimen development for TB	8
Chronic respiratory disease in adult outpatients in three African countries: a cross-sectional study	8
Two parallel pandemics: the challenges faced by countries with COVID-19 and TB	8
Opportunities to improve digital adherence technologies and TB care using human-centered design	7
A systematic review of the number needed to screen for active TB among people living with HIV	7
Minimal clinically important difference of the 6-min walking test in patients with asthma	7
TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up	7
Diurnal variability of fine-particulate pollution concentrations: data from 14 low- and middle-income countries	7
VIDAS^® TB-IGRA reagents induce a CD4⁺ and CD8⁺ T-cell IFN-γ response for both TB infection and active TB	7
Air conditioners, airborne infection prevention and air pollution in buildings in New Delhi	7
Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam	7
Vitamin D status and latent tuberculosis infection: conversion in nursing homes, Spain	7
Costs of TB services in India (No 1)	7
Knowledge, attitudes and practices on childhood TB among healthcare workers	7
The scientific response to TB – the other deadly global health emergency	7
Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian men	7
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	7
The Asthma Drug Facility and the future management of asthma	6
Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes	6
Continuity of TB services during the COVID-19 pandemic in China	6
COVID-19: ensuring continuity of TB services in the private sector	6
Key changes in the public health response to TB and HIV in South Africa	6
Vitamin D deficiency predicts latent TB reactivation independent of preventive therapy: a longitudinal study	6
Clinical standards for drug-susceptible pulmonary TB	6
Impact of influenza A co-infection with COVID-19	6
Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB	6
Vitamin D deficiency is associated with tuberculosis disease in British children	6
An Inca trail to the Holy Grail: digital medication adherence support for TB care	6
Impact of mental disorders on active TB treatment outcomes: a systematic review and meta-analysis	6
Continuous cough monitoring: a novel digital biomarker for TB diagnosis and treatment response monitoring	6
Setting up pharmacovigilance based on available endTB Project data for bedaquiline	6
Xpert^® MTB/RIF Ultra performance in diagnosing paediatric pulmonary TB in gastric aspirates	6
High yields from contact investigation of child index TB patients	6
Acceptability of levofloxacin, moxifloxacin and linezolid among children and adolescents treated for TB	6
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	6
Health-related quality of life associates with clinical parameters in patients with NTM pulmonary disease	6
The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination	6
Implementing 3HP vs. IPT as TB preventive treatment in Pakistan	6
Treatment outcomes and safety in children with rifampicin-resistant TB	6
Towards quality adolescent-friendly services in TB care	6
Effect of 6-month vs. 8-month regimen on retreatment success for pulmonary TB	6
The diagnosis of lung cancer in the era of interventional pulmonology	6
Opportunities to prevent and manage undernutrition to amplify efforts to end TB	6
Complications of tuberculous meningitis and their effect on outcome in a tertiary care cohort	6
QT prolongation in the STREAM Stage 1 Trial	6
The 100^th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-19	5
Increase in disseminated TB during the COVID‐19 pandemic	5
Time for a change: considering regimen changes in analyses of observational drug-resistant TB treatment cohort data	5
Determinants of treatment outcomes in patients with multidrug-resistant TB	5

Whole-genome sequencing differentiates relapse from re-infection in TB	5
Concern over a COVID-19-related BCG shortage	5
Face masks – a sustainable measure to mitigate COVID-19	5
Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB	5
Patterns of suboptimal adherence among adolescents treated for tuberculosis	5
Planning for TB elimination in Lebanon	5
Outdoor air pollution and respiratory health	5
A public health approach to increase treatment of latent TB among household contacts in Brazil	5
Seasonal drivers of tuberculosis: evidence from over 100 years of notifications in Cape Town	5
Work-related interstitial lung disease: what is the true burden?	5
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed	5
Tuberculosis trends in a hot-spot region in Paris, France	5
Post-TB bronchiectasis: from pathogenesis to rehabilitation	5
Measuring TB drug levels in the hair in adults and children to monitor drug exposure and outcomes	5
Cost of TB services in the public and private sectors in Georgia (No 2)	5
Country differences and determinants of yield in programmatic migrant TB screening in four European countries	5
Rapid development of a portable negative pressure procedural tent	5
Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: a cross-sectional study	5
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19	5
Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City	5
Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens	5
Characteristics of a “rebound” in smoking after a tobacco price increase	5
Fluoroquinolone preventive therapy for children exposed to MDR-TB	5
The effect of systematic screening of the general population on TB case notification rates	5
The economic burden of TB-affected households in DR Congo	5
Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines	5
Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy	5
Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens	4
GPT-4, artificial intelligence and implications for publishing	4
Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan	4
Completion of treatment for latent TB infection in a low prevalence setting	4
Screening for active and latent TB among migrants in France	4
Undernutrition can no longer be an afterthought for global efforts to eliminate TB	4
Is effective patient support missing in the global response to multidrug-resistant tuberculosis?	4
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB	4
COVID-19 in Africa: community and digital technologies for tuberculosis management	4
In Reply: How TB and COVID-19 compare: an opportunity to integrate both control programmes	4
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients	4
Effect of Global Fund financial support for patients with multidrug-resistant tuberculosis	4
Introducing new and repurposed TB drugs: the endTB experience	4
Systematic rifampicin resistance errors with Xpert^® MTB/RIF Ultra: implications for regulation of genotypic assays	4
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications	4
The Bedaquiline Donation Program: progress and lessons learned after 4 years of implementation	4
Reference values of impulse oscillometry (IOS) for healthy Indian adults	4
How mechanistic in silico modelling can improve our understanding of TB disease and treatment	4
Effect of malnutrition on the pharmacokinetics of anti-TB drugs in Ghanaian children	4
Isoniazid and verapamil modulatory activity and efflux pump gene expression in Mycobacterium tuberculosis	4
Disseminated Mycobacterium avium complex infection as a differential diagnosis of tuberculosis in HIV patients	4
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study	4
The impact of smoking on TB treatment outcomes includes recurrent TB	4
The impact of COVID-19 on the TB response: data from the field	4
COVID-19 and TB: a progression-regression conundrum	4
Effects of comorbidities on quality of life in Filipino people with tuberculosis	4
TB in older people in Asia: why it is important	4
Decreased notification of TB cases during the COVID-19 pandemic	4
Impact of COVID-19 on TB services in Korea	4
Seasonality, climate change and tuberculosis: new data and old lessons	4
Distinctive patterns of pulmonary function change according to baseline lung volume and diffusing capacity	4
Using a mobile application to improve pediatric presumptive TB identification in western Kenya	4
Clinical utility of target-based next-generation sequencing for drug-resistant TB	4
Impact of lung function on treatment outcome in patients with TB	4
How Big Tobacco uses disruptive tactics to deny child rights to be tobacco-free	4
COVID-19 and TB control in immigrant communities	4
Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus	4
Density of tobacco advertising around schools	4
Childhood TB in China: notification, characteristics and risk factors for outcomes, 2010–2017	4
Tobacco use and quitting behaviour during COVID-19 lockdown	4
Helping Africa to breathe when COVID-19 strikes	4
Adipokines and the risk of active TB: a nested case-control study	4
Post-TB disease: a new topic for investigation—and why it matters	4
A comparative analysis of asthma treatment guidelines and Essential Medicine Lists in sub-Saharan Africa	4
Preventive treatment of drug-resistant TB in a rural setting	4
Best practices for the care of pregnant people living with TB	4
Density of cigarette retailers around educational facilities in Indonesia	4
Global Asthma Report 2022: a wake-up call to enhance care and treatment for asthma globally	4
TB testing in HIV-positive patients prior to antiretroviral treatment	3
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults	3
Sputum culture conversion definitions and analytic practices for multidrug-resistant TB	3
Digital adherence technology for TB: focus on livelihoods as well as lives	3
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities	3
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease	3
Impact of the COVID-19 pandemic on TB infection testing	3
Use of chest radiography screening for TB: a re-evaluation of the Kolín study	3
Infection status of contacts is not associated with severity of TB in the index case	3
Diagnostic code agreement for electronic health records and claims data for tuberculosis	3
Diagnosis of paediatric TB using Xpert^® MTB/RIF Ultra on fresh respiratory samples	3
Reducing the burden of TB among migrants to low TB incidence countries	3
WHO target product profiles for TB preventive treatment	3
Introduction of bedaquiline for the treatment of drug-resistant TB in the Philippines	3
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline	3
Epidemiology and risk factors for extrapulmonary tuberculosis in Lebanon	3
Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali	3
High prevalence of pre-diabetes among people living with HIV in a high TB burden setting	3
Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era	3
Symptom and digital chest X-ray TB screening in South African prisons: yield and cost-effectiveness	3